Vecuronium bromide structure
|
Common Name | Vecuronium bromide | ||
|---|---|---|---|---|
| CAS Number | 50700-72-6 | Molecular Weight | 637.731 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H57BrN2O4 | Melting Point | 227-229°C | |
| MSDS | N/A | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Vecuronium bromideVecuronium bromide is a nondepolarizing neuromuscular blocking agent of intermediate duration. |
| Name | vecuronium bromide |
|---|---|
| Synonym | More Synonyms |
| Description | Vecuronium bromide is a nondepolarizing neuromuscular blocking agent of intermediate duration. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 227-229°C |
|---|---|
| Molecular Formula | C34H57BrN2O4 |
| Molecular Weight | 637.731 |
| Exact Mass | 636.350159 |
| PSA | 55.84000 |
| LogP | 2.86660 |
| InChIKey | VEPSYABRBFXYIB-PWXDFCLTSA-M |
| SMILES | CC(=O)OC1CC2CCC3C(CCC4(C)C3CC([N+]3(C)CCCCC3)C4OC(C)=O)C2(C)CC1N1CCCCC1.[Br-] |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-37/39 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933399090 |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome.
Am. J. Respir. Cell. Mol. Biol. 50(6) , 1031-9, (2014) Disturbances in respiration are common and debilitating features of Rett syndrome (RTT). A previous study showed that the 5-HT1a receptor agonist (R)-(+)-8-hydroxy-dipropyl-2-aminotetralin hydrobromid... |
|
|
Developing dual hemofiltration plus cardiopulmonary bypass in rodents.
J. Surg. Res. 195(1) , 196-203, (2015) Emerging therapies for prolonged cardiac arrest (CA) include advanced circulatory interventions like emergency cardiopulmonary bypass (ECPB) and continuous venovenous hemofiltration (CVVHF). However, ... |
|
|
Population of sensory neurons essential for asthmatic hyperreactivity of inflamed airways.
Proc. Natl. Acad. Sci. U. S. A. 111(31) , 11515-20, (2014) Asthma is a common debilitating inflammatory lung disease affecting over 200 million people worldwide. Here, we investigated neurogenic components involved in asthmatic-like attacks using the ovalbumi... |
| (2β,3α,5α,16β,17β)-3,17-Diacetoxy-16-(1-methyl-1-piperidiniumyl)-2-(1-piperidinyl)androstane bromide |
| MFCD00867762 |
| EINECS 256-723-9 |
| Vecuronium Bromide Hydrate |
| Piperidinium, 1-((2β,3α,5α,16β,17β)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromide |
| (2β,3α,5α,16β,17β)-3,17-bis(acetyloxy)-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide |
| Androstane-3,17-diol, 16-(1-methyl-1-piperidiniumyl)-2-(1-piperidinyl)-, bromide, diacetate (ester), (2β,3α,5α,16β,17β)- (1:1) |
| (2β,3α,5α,16β,17β)-3,17-Diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide |
| Vecuronium bromide |
| Norcuron |